Thus, circ_0080145/miR-203/ABL1 and circ_0051886/miR-637/ABL1 are two molecular axes being involved in imatinib resistance in CML [80]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.